Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Hormones
Published in: Hormones 3/2012

01-07-2012 | Research paper

Insulin resistance and risk of renal cell cancer: a case-control study

Authors: Themistoklis N. Spyridopoulos, Nick Dessypris, Antonis G. Antoniadis, Spyros Gialamas, Constantine N. Antonopoulos, Konstantina Katsifoti, Hans-Olov Adami, George P. Chrousos, Eleni Th. Petridou, MD, MPH, Giannopoulos Aris, Alivizatos Gerasimos, Vassilakis George, Kalogeropoulos Theodore

Published in: Hormones | Issue 3/2012

Login to get access
Metadata
Title
Insulin resistance and risk of renal cell cancer: a case-control study
Authors
Themistoklis N. Spyridopoulos
Nick Dessypris
Antonis G. Antoniadis
Spyros Gialamas
Constantine N. Antonopoulos
Konstantina Katsifoti
Hans-Olov Adami
George P. Chrousos
Eleni Th. Petridou, MD, MPH
Giannopoulos Aris
Alivizatos Gerasimos
Vassilakis George
Kalogeropoulos Theodore
Publication date
01-07-2012
Publisher
Springer International Publishing
Published in
Hormones / Issue 3/2012
Print ISSN: 1109-3099
Electronic ISSN: 2520-8721
DOI
https://doi.org/10.14310/horm.2002.1359

Other articles of this Issue 3/2012

Hormones 3/2012 Go to the issue

Research paper

Sex steroids and personality traits in the middle luteal phase of healthy normally menstruating young professional women

Review

The pluses and minuses of bariatric surgery for morbid obesity: An endocrinological perspective

Case report

Very premature pubarche in girls is not a pubertal variant

Case report

Parathyroid carcinoma as a challenging diagnosis: Report of three cases

Research paper

High TSH and low T4 as prognostic markers in older patients

Review

The “homeostasis hormone” and its CRF1 receptor. From structure to function
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits